Comparison of mathematical models for red marrow and blood absorbed dose estimation in the radioiodine treatment of advanced differentiated thyroid carcinoma

By Miranti A   Giostra A   Richetta E   Gino E   Pellerito R E   Stasi M  

Physics in Medicine and Biology, Vol. 60, Iss. 3, 2015-02 ,pp. : 1141-1157

IOP Publishing

Access to resources Recommend Favorite

Estimation personnalisée de la dose après totalisation isotopique par l’¹³¹I chez un patient présentant un goitre endothoracique résiduel

By Desbrée A.   Guyot M.   Ricard M.   Franck D.   Aubert B.   Challeton-de Vathaire C.  

Radioprotection, Vol. 50, Iss. 1, 2015-02 ,pp. : 11-17

Edp Sciences

Access to resources Recommend Favorite

All‐cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 3, 2018-02 ,pp. : 279-286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Myeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 2, Iss. 1, 2009-01 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Headache and Nausea after Treatment with High‐Dose Subcutaneous versus Intravenous Immunoglobulin

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 6, 2015-12 ,pp. : 409-412

John Wiley & Sons Inc

Access to resources Recommend Favorite